ERBB2 and breast carcinoma: Based on the routinely evaluated biological markers molecular subtypes of breast cancers have been classified as presence or absence of hormone (estrogen or progesterone) receptors (HR+/HR-) and presence or absence of excess levels of human epidermal growth factor receptor 2 (HER2+/HER2-).